Search
for
Sort by
Research 30 of 53
- Ritlecitinib (Litfulo)
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- Ritlecitinib: First Approval
- Ritlecitinib in severe alopecia areata: a profile of its use
- First drug for severe alopecia recommended by NICE could benefit 14,000 patients
- Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Methods of Using of Cosmeceuticals in Trichological Practice
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Lipid nanocarriers as innovative strategies for hair regrowth
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Novel drugs of United States Food and Drug Administration approved in 2024
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis
- Exploring Factors That Influence the Measurement of Patient-Reported Impacts of Alopecia Areata
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- USE OF RITLECITINIB FOR THE TREATMENT OF ALOPECIA AREATA
- Alopecia Areata: Current Treatments and New Directions
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto ( <i>Serenoa repens</i> ) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self‐Perceived Thinning Hair: 90‐Day Results
- 0433 JAK inhibitor halts the progression of acute exacerbation of alopecia areata
- Aim to alleviate alopecia areata with newly available agents